MyHealthTeam Posters Featured at AANAM 2025

Today, representatives from MyHealthTeam, a Swoop company, presented our latest research featured in two posters at the American Academy of Neurology 2025 Annual Meeting. These latest findings are the most recent examples of how Swoop is transforming patient care.

Patient Reported Attitudes Towards Multiple Sclerosis Treatment

Authors: Dianna Cronin (MyHealthTeam) and Beth Schneider (MyHealthTeam)

OBJECTIVE
Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.

Click the image to download. 

MHT_AAN_MS-Poster SWOOP

Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters!

Authors: James W. Wheless, BScPharm, M.D., FAAP, FACP, FAAN, FAES, Le Bonheur Children’s Hospital, Heather Lapidus Glassner, MyHealthTeam, Dianna Higgins Cronin, MyHealthTeam

OBJECTIVE
To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy.

Click the image to download.

MHT_AAN-Epilepsy-Azurity-Poster_2760_02.28.25.FINAL

Our research team delivers rapid patient insights that inform brand strategies. Contact us to learn more.

Swoop
Swoop
Transforming Omnichannel

Swoop is a leading provider of AI-driven, precision healthcare omnichannel solutions dedicated to protecting consumer privacy and improving patient outcomes. By prioritizing privacy and compliance, Swoop delivers industry-leading audience segments, 100% MLR-approved conversational AI agents, and now a leading opted-in patient social network in the U.S. through its acquisition of MyHealthTeam. Swoop’s solutions drive meaningful patient and provider engagement, optimal conversion, and measurable increases in Rx lift across the patients’ health journey.